This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Debiopharm S.a., Katholieke Universiteit Leuven. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 28 
1 out of 631 
Years Active: 2014
Title: Sonia Van Dooren: Innovator in Hepatitis C Research
Introduction
Sonia Van Dooren is a notable inventor based in Meise, Belgium. She has made significant contributions to the field of medical research, particularly in the area of Hepatitis C Virus (HCV) drug resistance. Her work has implications for the development of more effective treatments for this viral infection.
Latest Patents
Sonia holds a patent for a "Near full-genome assay of HCV drug resistance." This invention relates to assays that characterize genotypic mutations of the Hepatitis C Virus, which show resistance to anti-HCV drugs. This advancement is crucial for improving treatment strategies for patients affected by HCV.
Career Highlights
Throughout her career, Sonia has worked with prominent organizations, including Debiopharm S.A. and Katholieke Universiteit Leuven. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sonia has collaborated with esteemed colleagues such as Anne-Mieke Vandamme and Joke Snoeck. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Sonia Van Dooren's innovative contributions to Hepatitis C research highlight her role as a key figure in the fight against viral infections. Her patent on HCV drug resistance assays represents a significant step forward in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile